title: HPMA copolymer-based polymer conjugates for the delivery and controlled release of retinoids.
abstract: In this paper, we describe the synthesis, physicochemical characterization, drug release kinetics and preliminary biological evaluation of several N-(2-hydroxypropyl)methacrylamide (HPMA)-based polymer-retinoid conjugates designed for solid tumor immunotherapy. The conjugates are supposed to inhibit the immunosuppressive activity of myeloid-derived suppressor cells (MDSC) accumulated in the solid tumor microenvironment. All-trans retinoic acid (ATRA) was derivatized to hydrazide (AtrHy) and then attached to the polymer backbone via a spacer that is stable at the normal pH of blood (7.4) and hydrolytically degradable in mildly acidic environments (e.g. in endosomes or lysosomes, pH~5.0-6.5). Polymer-AtrHy conjugates were designed to achieve prolonged blood circulation and release of the immunomodulator intracellularly or extracellularly in solid tumor tissue. Three types of polymer precursors, differing in the structure of the keto acid-containing side chains, were synthesized. A linkage susceptible to hydrolytic cleavage was formed by the conjugation reaction of the carbonyl group-terminated side chains of the polymer precursors with the hydrazide group of a drug derivative. In vitro incubation of the conjugates in buffers resulted in much faster release of the drugs or their derivatives from the polymer at pH 5.0 than at pH 7.4, with the rate depending on the detailed structure of the spacer. Both the AtrHy derivative and its polymer conjugates showed the ability to induce the differentiation of retinoid-responsive HL-60 cells, thus demonstrating the required biological activity.
authors.affiliation: Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic. etrych@imc.cas.cz.
authors.forename: O
authors.initials: O
authors.lastname: Lidický
authors.forename: M
authors.initials: M
authors.lastname: Šírová
authors.forename: T
authors.initials: T
authors.lastname: Etrych
mesh_terms: D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D004337:Drug Carriers / Q000138:chemical synthesis*; D018922:HL-60 Cells; D006801:Humans; D008689:Methacrylates / Q000737:chemistry*; D014212:Tretinoin / Q000493:pharmacokinetics*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D008689:Methacrylates; D014212:Tretinoin; C032802:hydroxypropyl methacrylate